To ensure greater affordability of cancer treatments and sustainability of insurance premiums for Singaporeans in the longer term, the MediShield Life Council set up a Cancer Drug Committee in 2021 to review coverage for outpatient cancer drug treatments to support Singaporeans’ continued access to good and affordable care.
From 1 September 2022, MediShield Life and MediSave coverage for outpatient cancer treatment have been adjusted. MediShield Life will:
(i) cover a list of clinically proven and more cost-effective cancer drug treatments (“Cancer Drug List”, CDL) at more granular claim limits ranging from $200 to $9,600 per month to provide more targeted coverage based on the cost of each cancer drug treatment; and
(ii) allow patients to tap on a separate claim limit for cancer drug services, which include scans, blood tests and doctor consultations and supportive care drugs. The claim limit was increased from $1,200 per year to $3,600 per year from 1 April 2023.
MediSave withdrawal limits for outpatient cancer drug treatments and scans have also been adjusted together with the changes for MediShield Life.
Please refer to the table below for the current and revised MediShield Life and MediSave limits:
